Published by Benjamin Chiou on 13th September 2024
(Sharecast News) - China's health authority has granted GSK's Blenrep blood cancer treatment with a so-called 'Breakthrough Therapy Designation' (BTD), which is designed to speed up development of investigational drugs.
URL: http://www.digitallook.com/dl/news/story/34553593/...